Carmen J. Ostermeier

Chief Development Officer (cdo) at Headlands Research - AMCR Institute

Carmen J. Ostermeier serves as the Chief Development Officer and President of Headlands Research - AMCR Institute since June 2017, where significant growth in medical device expertise has been achieved. Prior to this role, Carmen was the Chief Development Officer and Sr. Director of Development at ProSciento, Inc. from September 2009 to December 2016, with a career advancement from Manager of Business Development. Carmen's experience also includes a tenure as Sr. Key Account Sales Manager for Diabetes Care at MENARINI Group and earlier positions in sales and management at APS Pharma GmbH and Alliance Healthcare Deutschland AG. Carmen holds a Master of Science in Pharmacology and Toxicology and a PharmD in Pharmacology from Universität Greifswald and Medizinische Akademie Carl Gustav Carus, respectively.

Links

Previous companies

ProSciento, Inc. logo